Research Horizons


Proton Therapy Center Leads Clinical Trial of FLASH Therapy

The first human clinical trial of FLASH therapy, a new method of proton therapy for cancer, reached an important milestone in October 2021.

Enrollment is complete for FAST-01 (FeAsibility Study of FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases), according to a news release from Varian, the manufacturer of the system that delivers the therapy.

The FAST-01 trial is being led by John Breneman, MD, principal investigator, and Medical Director of the Cincinnati Children’s/UC Health Proton Therapy Center.

The $120 million Proton Therapy Center, located at Cincinnati Children’s Liberty Township campus, marked its five-year anniversary in October.

Read Varian’s announcement about the clinical trial  

Read more from John Perentesis MD, FAAP, about FLASH